Moderna Inc. stock rises Monday, outperforms market
Shares of Moderna Inc. rose 9.28% to $233.70 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.05% to 14,942.83 and the Dow Jones Industrial Average falling 0.45% to 36,068.87. Moderna Inc. closed $263.79 short of its 52-week high ($497.49), which the company achieved on August 10th.
Video: Stock market returns won't be 'enormous' in 2022, analyst says (CNBC)
-
We have not seen any signs of a recession yet, says Deutsche Bank's Binky Chadha Binky Chadha, Deutsche Bank chief global strategist, joins CNBC's 'Squawk Box' to discuss whether he's forecasting a recession in the near future and this week's market action.
CNBC
-
McDonald's shareholders set to vote on proxy fight over animal welfare practices CNBC's Kate Rogers joins 'Squawk on the Street' to break down what investors can expect from McDonald's annual shareholder meeting.
CNBC
-
Opening Bell, May 26, 2022 Watch the opening bell for the Nasdaq and the New York Stock Exchange from May 26, 2022.
CNBC
The stock outperformed some of its competitors Monday, as AbbVie Inc. rose 1.12% to $136.39, Amgen Inc. rose 1.36% to $230.37, and AstraZeneca PLC ADR rose 0.70% to $57.88. Trading volume (17.1 M) eclipsed its 50-day average volume of 12.4 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
More from Marketwatch
-
The long history of racism haunts Black professionals, and the best places to work in America recognize and respect this
MarketWatch
-
This pacifist, faith-based fund-management company is fighting gun violence in its own way
MarketWatch
-
Fed’s Brainard says recent crypto ‘turmoil’ could make the case for a digital dollar
MarketWatch